Picture of 3i logo

III 3i News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedLarge CapContrarian

REG - 3i Group PLC - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260130:nRSd1522Ra&default-theme=true

RNS Number : 1522R  3i Group PLC  30 January 2026

Director/PDMR Shareholdings

 

UK Market Abuse Regulation Article 19

 

Pursuant to the rules of The 3i Group Share Incentive Plan, on 30 January 2026
each of the Directors/persons discharging managerial responsibilities
("PDMRs") of 3i Group plc (the "Company") (LEI: 35GDVHRBMFE7NWATNM84) listed
below became beneficially interested in the total number of ordinary shares of
73 19/22p each (ISIN: GB00B1YW4409) in the Company ("Shares") shown against
their name below, such Shares consisting of:

 

 (a)  Partnership Shares, which were purchased at a subscription price of 3235.0
      pence per Share;

 (b)  Matching Shares, which were awarded for nil consideration; and

 (c)  Dividend Shares, which were purchased at a subscription price of 3235.0 pence
      per Share, following a dividend re-investment.

 

                  Partnership Shares  Matching Shares  Dividend  Total

                                                       Shares    Shares
 Directors/PDMRs
 K J Dunn         5                   10               288       303
 J H Halai        5                   10               281       296
 A Lissaman       5                   10               159       174
 J Marie          5                   10               296       311
 B Sottomayor     5                   10               55        70

 

The Company was notified of the above transactions on 30 January 2026.  These
transactions took place outside a Trading Venue.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHWPUPPGUPQGCU



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on 3i

See all news